Cargando…

Pulmonary Arterial Hypertension in Hispanics

Pulmonary hypertension (PH) is a medical condition characterized by elevated pressures in the pulmonary vessels. Pulmonary arterial hypertension (PAH), or pre-capillary PH, is a subgroup of the broader PH definition. PAH is rare compared to other groups of PH; its prevalence is about 15 cases per mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, Raiko, Ferrer, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827697/
https://www.ncbi.nlm.nih.gov/pubmed/31754569
http://dx.doi.org/10.7759/cureus.5834
_version_ 1783465341411655680
author Diaz, Raiko
Ferrer, Gustavo
author_facet Diaz, Raiko
Ferrer, Gustavo
author_sort Diaz, Raiko
collection PubMed
description Pulmonary hypertension (PH) is a medical condition characterized by elevated pressures in the pulmonary vessels. Pulmonary arterial hypertension (PAH), or pre-capillary PH, is a subgroup of the broader PH definition. PAH is rare compared to other groups of PH; its prevalence is about 15 cases per million in the adult population. Several disease processes may lead to PAH; however, the most common cause of PAH is idiopathic. Until recently, treatment for PAH was very limited and prognosis was dismal. Limitations in management remain present today but more treatment options are available for patients suffering from this condition.  Most of the information available regarding PAH comes from registries in the United States and Europe. Limited information about epidemiology, treatment options, and response to the treatment is available for other ethnic groups such as Hispanics. In the world of medicine, we have learned from other more common medical conditions that components, such as genetics, environment, and culture may affect how diseases manifest and how they respond to treatment. It is important to be aware of how different ethnic groups exposed to different environmental conditions respond to different treatment modalities. The aim of this paper is to review the limited data available regarding PAH in Hispanics. This paper will review the information regarding the etiology, diagnosis, and treatment modalities available in South American and Central American countries. This paper will also review the data available for Hispanics diagnosed with PAH living in the United States. The goal is to highlight the difference in how PAH manifests in Hispanics compared to other ethnic groups. We aim to emphasize the importance of the lack of data available for this group and how it may be affecting the way we are treating Hispanics with PAH. 
format Online
Article
Text
id pubmed-6827697
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68276972019-11-21 Pulmonary Arterial Hypertension in Hispanics Diaz, Raiko Ferrer, Gustavo Cureus Pulmonology Pulmonary hypertension (PH) is a medical condition characterized by elevated pressures in the pulmonary vessels. Pulmonary arterial hypertension (PAH), or pre-capillary PH, is a subgroup of the broader PH definition. PAH is rare compared to other groups of PH; its prevalence is about 15 cases per million in the adult population. Several disease processes may lead to PAH; however, the most common cause of PAH is idiopathic. Until recently, treatment for PAH was very limited and prognosis was dismal. Limitations in management remain present today but more treatment options are available for patients suffering from this condition.  Most of the information available regarding PAH comes from registries in the United States and Europe. Limited information about epidemiology, treatment options, and response to the treatment is available for other ethnic groups such as Hispanics. In the world of medicine, we have learned from other more common medical conditions that components, such as genetics, environment, and culture may affect how diseases manifest and how they respond to treatment. It is important to be aware of how different ethnic groups exposed to different environmental conditions respond to different treatment modalities. The aim of this paper is to review the limited data available regarding PAH in Hispanics. This paper will review the information regarding the etiology, diagnosis, and treatment modalities available in South American and Central American countries. This paper will also review the data available for Hispanics diagnosed with PAH living in the United States. The goal is to highlight the difference in how PAH manifests in Hispanics compared to other ethnic groups. We aim to emphasize the importance of the lack of data available for this group and how it may be affecting the way we are treating Hispanics with PAH.  Cureus 2019-10-04 /pmc/articles/PMC6827697/ /pubmed/31754569 http://dx.doi.org/10.7759/cureus.5834 Text en Copyright © 2019, Diaz et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pulmonology
Diaz, Raiko
Ferrer, Gustavo
Pulmonary Arterial Hypertension in Hispanics
title Pulmonary Arterial Hypertension in Hispanics
title_full Pulmonary Arterial Hypertension in Hispanics
title_fullStr Pulmonary Arterial Hypertension in Hispanics
title_full_unstemmed Pulmonary Arterial Hypertension in Hispanics
title_short Pulmonary Arterial Hypertension in Hispanics
title_sort pulmonary arterial hypertension in hispanics
topic Pulmonology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827697/
https://www.ncbi.nlm.nih.gov/pubmed/31754569
http://dx.doi.org/10.7759/cureus.5834
work_keys_str_mv AT diazraiko pulmonaryarterialhypertensioninhispanics
AT ferrergustavo pulmonaryarterialhypertensioninhispanics